Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, 3501 Terrace Street, Pittsburgh, PA 15261, USA.
Expert Opin Drug Metab Toxicol. 2011 Jul;7(7):803-16. doi: 10.1517/17425255.2011.574127. Epub 2011 Apr 8.
Therapeutic hypothermia is being employed clinically due to its neuro-protective benefits. Both critical illness and therapeutic hypothermia significantly affect drug disposition, potentially contributing to drug-therapy and drug-disease interactions. Currently, there is limited information on the known alterations in drug concentration and response during mild hypothermia treatment, and there is a limited understanding of the specific mechanisms that underlie alterations in drug concentrations and the potential clinical importance of these changes.
A systemic review of the effect of therapeutic hypothermia on drug metabolism, disposition and response is provided. Specifically, the clinical and preclinical evidence of the effects of therapeutic hypothermia on blood flow, specific hepatic metabolism pathways, transporter function, renal excretion, pharmacodynamics and the effects during rewarming are reviewed.
Available evidence demonstrates that mild hypothermia decreases the clearance of a variety of drugs with apparently little change in drug-protein binding. Recent evidence suggests that the magnitude of the change is elimination route specific. Further research is needed to determine the impact of these alterations on both drug concentration and response in order to optimize the therapeutic hypothermia in this vulnerable patient population.
由于其神经保护作用,治疗性低温正在临床应用。危重病和治疗性低温都会显著影响药物处置,可能导致药物治疗和药物-疾病相互作用。目前,关于轻度低温治疗期间药物浓度和反应的已知变化的信息有限,并且对导致药物浓度变化的具体机制以及这些变化的潜在临床重要性的了解有限。
提供了治疗性低温对药物代谢、处置和反应的影响的系统评价。具体来说,回顾了治疗性低温对血流、特定肝代谢途径、转运蛋白功能、肾脏排泄、药效学以及复温期间的影响的临床前和临床证据。
现有证据表明,轻度低温会降低多种药物的清除率,而药物蛋白结合似乎变化不大。最近的证据表明,变化的幅度与消除途径特异性有关。需要进一步研究以确定这些变化对药物浓度和反应的影响,以便优化这一脆弱患者群体的治疗性低温。